Readers gain insights into such important questions as follows: How can we help victims in other countries? What (if any) responsibility should be placed upon international organizations whose actions exacerbate infectious diseases? How can we ensure that pharmaceutical research helps all communities, even those who cannot afford to pay for the products?
While broadly covering global health law, the book adopts an inter-disciplinary approach that draws on public international law, philosophy, international relations, human rights law, and healthcare economics. As such, it is a valuable resource for academic libraries, appealing to scholars and postgraduates engaged in relevant research, as well as to those engaged with global health and policy at the international level.
Chapter 'R&D for emerging infectious diseases of epidemic potential: sharing risks and benefits through a new coalition' is available open access under a CC by 4.0 license via link.springer.com.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.